Haleon

Haleon plc is a British multinational consumer healthcare company based in Weybridge, England. Established on July 18, 2022, as a spin-off from GlaxoSmithKline, Haleon focuses on delivering better everyday health through science-backed products. The company operates in categories such as oral health, pain relief, respiratory health, digestive health, and vitamins, minerals, and supplements (VMS). It features a portfolio of well-known brands, including Sensodyne, Panadol, Voltaren, Advil, Centrum, and Theraflu, generating net revenue of £10.6 billion in 2022. With a workforce of approximately 22,000, Haleon serves over 100-170 markets worldwide. The company emphasizes innovation and efficiency, leveraging cloud technology and optimizing operations to enhance its presence in the $220 billion consumer health industry. Haleon is committed to improving health outcomes and operates with a mission to deliver better everyday health with humanity.